<DOC>
	<DOCNO>NCT01914627</DOCNO>
	<brief_summary>The study conduct evaluate efficacy safety topical dimeticone formulation ( Loion® ) compare 10 % salicylic acid octyl-dodecanol 15 % Macrogol-4-laurylether removal scale patient chronic psoriasis capitis ( scalp psoriasis ) .</brief_summary>
	<brief_title>Parallel Group Trial Evaluate Efficacy Safety Loion® Compared 10 % Salicylic Acid Patients With Chronic Psoriasis Capitis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>Patients ≥ 18 year age Having diagnosis chronic psoriasis capitis ( scalp psoriasis ) without involvement body area without psoriatic arthritis . PSSI ≥5 ( range 072 ) Scaling ≥2 ( scale 0 4 ) At least 10 % scalp area affect If woman : Postmenopausal Premenopausal use establish oral , injected implant hormonal method contraception , intrauterine device ( IUD ) intrauterine system ( IUS ) Negative pregnancy test inclusion Patients concomitant systemic psoriasis medication . Willingness adherence prohibition restriction specify study protocol . Willingness selfadminister drug . Signed informed consent document indicate patient include understands purpose procedure study willing participate . Patients solely non plaque form psoriasis ( e.g . erythrodermic , guttate , pustular ) . Patients uncontrolled psoriasis current treatment . Patients receive topical keratolytic agent scalp within past 2 week topical steroid scalp within past week ( prior inclusion ) . Patients receive systemic antipsoriatic drug , immunosuppressant systemic corticosteroid ( within 4 week prior inclusion ) . Women pregnant breastfeeding planning become pregnant observational period . Patients participate another study use investigational agent procedure participation study observation period . Known hypersensitivity ingredient investigational product ' formulation . Having condition opinion investigator make participation best interest subject . Employees staff investigator study site direct involvement study well family member employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Psoriasis capitis</keyword>
	<keyword>Scaling</keyword>
	<keyword>Salicylic acid</keyword>
	<keyword>Dimethicone</keyword>
	<keyword>Plaque removal</keyword>
</DOC>